News

Historic agreement with UAE signed

Supporting future Grangemouth industries

Biotech innovator set to scale-up its sustainable algal Omega 3 production to meet rising demand from petfood and aquaculture markets

PXN Ventures, the fastest-growing venture-focused investment firm outside London and the South East, joins existing shareholders to support Orbital’s commercial tidal-stream projects, following new tidal energy licences in Canada

Pioneering molecular diagnostics company MI:RNA, which uses biomarkers and advanced modelling to diagnose veterinary disease earlier, has reached a growth milestone with the completion of an oversubscribed funding round.

A pioneering digital platform, dedicated to trauma prevention and management for frontline professionals, has secured funding of £1.2m from investors.

Investment comes after surging demand for Rhizocore’s fungal tree health pellets.

1nhaler, a Scotland-based drug delivery device developer, has secured an additional £1.5 million in seed funding to drive development of its novel pop-up cardboard dry powder inhaler (DPI).

Scottish Brain Sciences (SBS), a leading clinical research organisation dedicated to transforming the early detection and treatment of Alzheimer’s disease and other neurodegenerative conditions, has opened a new state-of-the-art clinical research centre at ONE BioHub, Aberdeen.

SOLASTA® Bio, specialising in the next generation of green insecticides, has relocated to purpose-built facilities at the West of Scotland Science Park, marking a major milestone in the company's growth journey since 2021.

Scottish Enterprise is launching the next phase of its successful US MarketBooster programme, supporting innovative science and tech companies to enter and scale in the world’s largest market for technology products and services.

A Scottish company has been awarded funding to develop a tool for earlier diagnosis of canine osteoarthritis (OA) – a disease which affects up to 20% of dogs worldwide.